Form 13-F position report

IMMUNOGEN INC

Reported by STATE STREET CORPORATION

IMGN CUSIP 45253H101 Manager CIK 0000093751

Reported 18,199,554 shares, up 4,492,165 (32.8%) from the prior quarter.

Reported value 25.5%; share count 32.8% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 18,199,554 Quarter-end amount reported
Reported value $81,898,000 Fair value at quarter end
Consecutive quarters held 37 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 59869000
2022-03-31 65247000
2022-06-30 81898000
2022-09-30 69763000
2022-12-31 86840240
2023-03-31 65575519
2023-06-30 149807307
2023-09-30 151587891
2023-12-31 239443645
2024-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

10 quarters
Quarterly reported position history for IMMUNOGEN INC held by STATE STREET CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2024 Reduced 0 -8,075,671 (-100.0%) 0 $0 2024-05-15
Q4 2023 Reduced 8,075,671 -1,476,181 (-15.5%) 0.01% $239,443,645 2024-02-14
Q3 2023 Added 9,551,852 +1,612,938 (20.3%) < 0.01% $151,587,891 2023-11-14
Q2 2023 Reduced 7,938,914 -9,138,044 (-53.5%) < 0.01% $149,807,307 2023-08-14
Q1 2023 Reduced 17,076,958 -431,155 (-2.5%) < 0.01% $65,575,519 2023-05-15
Q4 2022 Added 17,508,113 +2,913,240 (20.0%) < 0.01% $86,840,240 2023-02-14
Q3 2022 Reduced 14,594,873 -3,604,681 (-19.8%) < 0.01% $69,763,000 2022-11-15
Q2 2022 Added 18,199,554 +4,492,165 (32.8%) < 0.01% $81,898,000 2022-08-15
Q1 2022 Added 13,707,389 +5,638,822 (69.9%) < 0.01% $65,247,000 2022-05-16
Q4 2021 Reduced 8,068,567 -997,290 (-11.0%) < 0.01% $59,869,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

224 managers reported IMMUNOGEN INC for Q2 2022.

Managers reporting IMMUNOGEN INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
RA CAPITAL MANAGEMENT L P Unchanged 21,741,458 0 2.61% $97,837,000 10 qtrs
STATE STREET CORPORATION This report Added 18,199,554 +4,492,165 < 0.01% $81,898,000 37 qtrs
BlackRock Inc Added 17,877,269 +1,444,336 < 0.01% $80,448,000 37 qtrs
VANGUARD GROUP INC Added 16,059,020 +580,504 < 0.01% $72,266,000 37 qtrs
DEERFIELD MANAGEMENT COMPANY L P SERIES C Added 15,020,490 +11,549,815 1.39% $67,592,000 2 qtrs
ADAGE CAPITAL PARTNERS GP L L C Unchanged 11,586,193 0 0.12% $52,138,000 7 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 10,717,085 -2,346,399 < 0.01% $48,227,000 20 qtrs
Redmile Group LLC Reduced 9,141,045 -76,900 1.57% $41,135,000 22 qtrs
MORGAN STANLEY Added 5,485,767 +241,147 < 0.01% $24,686,000 37 qtrs
Clearbridge Investments LLC Reduced 5,372,065 -130,778 0.02% $24,174,000 37 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
17,789,050
Shared
0
None
410,504

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.